Grants & You Nov/Dec 2014

Featured Items

Federal RePORTer

  The National Institutes of Health (NIH) is currently collaborating on an initiative of the STAR METRICS® program to create Federal RePORTer, a searchable database of scientific awards from multiple federal agencies, still in alpha testing. This tool allows users to search for collaborative investigators working in similar research areas, find reviewers, see scientific advances in specific fields, and see the impact of funding across multiple agencies. This site offers a familiar interface for users who have conducted searches on the NIH RePORTER, which allows advanced text searches, searches across all or only a few agencies, fiscal year selection, and more. While the NIH RePORTER holds NIH-funded research and projects from other organizations currently using the electronic Research Administration (eRA) systems, Federal RePORTer contains additional research projects funded by:

• National Institutes of Health (NIH)
• Centers for Disease Control and Prevention (CDC)
• Food and Drug Administration (FDA)
• Administration for Children and Families (ACF)
• Agency for Healthcare Research and Quality (AHRQ)
• Environmental Protection Agency (EPA)
• National Aeronautics and Space Administration (NASA)
• National Science Foundation (NSF)
• Department of Veterans Affairs (VA)
• Center for Neuroscience and Regenerative Medicine (CNRM)
• Medical Research Programs of the Department of Defense (DOD)
• US Department of Agriculture (USDA)

New Internal Support for Research/Scholarly Activity at ATSU

  In response to a recent self-study to assess faculty interests and needs for research and scholarly activity at ATSU, the Office of the President has announced the following intramural funding commitments:

  Increase and ensure funding of faculty scholarly activity grant opportunities.

  $200,000 per year will be available through the ATSU internal grants program – effective immediately
With this commitment of annual funding, ATSU will move from primarily relying on endowment returns to fund internal grant scholarly activity.

  Encourage and support research focused on improving patient and population health outcomes.

  Up to $350,000 for internal grant funding – effective immediately and available until exhausted
ATSU will join forces with the National Association of Community Health Centers (NACHC) and Health Resources and Services Administration (HRSA) to develop collaborative research opportunities targeting national priorities. NACHC and HRSA support ATSU in many ways, including access to clinical rotations; introductions to potential funding partners; residency development; data gathering; student scholarship opportunities; and national exposure of our schools, programs, faculty, and students.

  Areas for scholarly activity under this program may include:

• Developing, implementing, and assessing evidence-based medicine guidelines.
• Diagnosing, preventing, and treating diabetes, obesity, skin cancer, metabolic syndrome, traumatic brain injury/concussions, spine pain, and HIV/AIDS.
• Evaluating oral health disease prevention and treatment programs.
• Measuring and encouraging physical activity and its impact on health and wellness.
• Designing, organizing, and evaluating population management teams and patient navigator models CHCs.

  *Proposals are encouraged to feature interprofessional cooperation, inter-campus partnering, collaboration between basic and clinical scientists, and incorporation of clinical teaching sites.

  Continue and expand other support for faculty participating in scholarly activity.

• Produce a bi-annual print and digital magazine, focusing on scholarly activity and participating faculty.
  • First publication, FY 2015-16

   

 

• Create a “Scholarship Day/Week” promoting diverse forms of research with faculty serving as peer reviewers for internal presentations. $2,500 immediately available for each campus and the College of Graduate Health Sciences

  Beginning FY 2015-16:

• Establish a travel fund to support faculty presenting scholarly activity during conferences. $20,000
• Fund a capital budget for research to provide a standardized process for equipment purchase and replacement. $25,000 for each campus
• Recognize faculty for publishing scholarly activity in peer-reviewed journals. $10,000
• Implement a mentoring program for faculty interested in scholarly activity. $10,000

5th Annual Ohio Osteopathic Symposium Poster Competition and Exhibition

  Saturday, April 25, 2015 | Columbus, OH
Submission Deadline: January 31, 2015
Sponsored by the Ohio University Heritage College of Osteopathic Medicine Centers for Osteopathic Research and Education (CORE) and the Ohio Osteopathic Association (OOA).

  Students, interns/residents, faculty, practicing physicians, and medical administrators are eligible to exhibit. Only osteopathic students, interns, and residents are eligible for the competition/prizes.

  Categories:

• Biomedical/Clinical Research
• Case Reports
• Exhibition/Health Policy/Educational Issues (restricted to faculty/administrators)

  Prizes Awarded (Biomedical/Clinical Research and Case Reports categories):

• $1,000 (first place)
• $500 (second place)
• $750 (Ohio ACOFP poster award – new for 2015) – only DO residents in an Ohio Family Medicine residency (ACGME or AOA) are eligible.

  For more details: Karen Collins, MPA, CORE Research Grant Writer/Editor | 740.593.2322| collink3@ohio.edu
Call for Abstracts Flyer
Poster Abstract Submission Form

RFI on the National Institute on Aging Strategic Directions for Research – NOT-AG-15-001

  The National Institute on Aging (NIA) is updating its Strategic Directions to help guide the research it supports over the next five years. Public input on the topics to be included in the plan and suggestions regarding how to enhance the NIA research portfolio are critical initial steps in this effort. Through this Request for Information (RFI), the NIA invites feedback from researchers in academic and industry, healthcare professionals, patient advocates, and health advocacy organizations, scientific or professional organizations, federal agencies, and other interested members of the public. Organizations are strongly encouraged to submit a single response that reflects the views of their organization and membership as a whole. Perspectives requested:

1. Research needs and opportunities that should be modified because of progress over the past five years and
2. Emerging research needs and future opportunities that should be added to the plan.

  Responses will be accepted until December 15, 2014, via email to niaplanning@nia.nih.gov. NIA leadership and staff will review and consider comments as the Institute updates its Strategic Directions.

Clarification of 4-Year Limit of Postdoctoral Research Eligibility for K99 Applicants – NOT-OD-15-013

  The NIH recently released NOT-OD-15-013 to clarify the eligibility requirement that NIH Pathway to Independence Award (K99) applicants must have no more than four years of postdoctoral research experience at the time of the initial application or resubmission or revision. This notice describes situations in which time is not counted against the four-year limit. Eligibility was modified to add the following statement:

  Parental leave or other well-justified leave for pressing personal or family situations of generally less than 12 months duration (e.g., family care responsibilities, disability or illness, active military duty) is not included in the 4-year eligibility limit. In addition, time spent conducting postgraduate clinical training that does not involve research is not considered as part of the 4-year research training eligibility limit. Only time dedicated to research activities would count toward the 4-year limit.

  Additional clarifications are provided under Frequently Asked Questions. Potential candidates are encouraged to discuss their individual situation with an NIH Institute or Center scientific program contact before applying.

Revised NIH Definition of Clinical Trial – NOT-OD-15-015

  The NIH has revised their definition of “clinical trial” to clarify the distinction between clinical trials and clinical research studies and to enhance the precision of the information NIH collects, tracks, and reports on clinical trials. The revision is not intended to expand the scope of the category of clinical trials. No changes were made to the NIH definition of a “Phase III clinical trial.” The revised NIH definition of a clinical trial is:

  A research study in which one or more human subjects are prospectively assigned to one or more interventions (which may include placebo or other control) to evaluate the effects of those interventions on health-related biomedical or behavioral outcomes.

  Clinical trials are subject to additional oversight. NIH believes this clearer definition will help investigators ensure they are meeting all obligations and will help NIH ensure additional oversight occurs when needed. The revised definition will replace the current clinical trial definition in relevant extramural and intramural NIH policies, guidance, and instructional materials and will apply to competing grant applications submitted to NIH on or after January 25, 2015.